论文部分内容阅读
肝硬化门静脉高压症祖国医学归属于癥、瘕、痞、积范畴。姜春华认为肝病包括早、晚期肝硬化,主要是血滞,带来气滞,所以治疗首先应考虑活血,以活血化瘀为主,即使晚期肝硬化腹水仍以此法为主。中国医学科学院曾应用现代血液流变学,尤其是微循环的理论、技术和方法,对各种血瘀证进行了实验研究,结果表明各种血瘀证患者多显示全身或局部的血液流变学异常。经活血化瘀治疗,随病情缓解或好转,血液流变学异常或微循环障碍也得到改善或纠正。基于这些理论,我们设想活血化瘀对于早、晚期肝硬化具有一定疗效,也有可能降低门静脉压力。为了探索中西医结合治疗肝硬化门静脉高压症,提高治疗门脉高压疗效,研究复方丹参
Liver cirrhosis of portal hypertension in the motherland medicine belongs to the category of disease, delirium, fistula, and product. Jiang Chunhua believes that liver disease includes early and late liver cirrhosis, which is mainly due to blood stagnation, which brings about qi stagnation. Therefore, treatment should first consider blood circulation, mainly by promoting blood circulation, even if the advanced liver cirrhosis is still based on this method. The Chinese Academy of Medical Sciences had applied modern hemorheology, especially the theory, techniques, and methods of microcirculation, and conducted experimental research on various blood stasis syndromes. The results showed that patients with various blood stasis syndromes showed systemic or local blood rheology. Abnormal learning. After treatment with blood circulation, blood rheology abnormalities or microcirculatory disturbances are also improved or corrected as the condition is relieved or improved. Based on these theories, we hypothesize that blood circulation therapy has a certain effect on early and late liver cirrhosis, and it may also reduce portal pressure. In order to explore the treatment of liver cirrhosis and portal hypertension with the combination of Chinese and Western medicine, to improve the efficacy of treatment of portal hypertension, study the compound salvia miltiorrhiza